Invention Grant
- Patent Title: Fused pyrroledicarboxamides and their use as pharmaceuticals
-
Application No.: US15041541Application Date: 2016-02-11
-
Publication No.: US09884860B2Publication Date: 2018-02-06
- Inventor: Laurent Bialy , Katrin Lorenz , Klaus Wirth , Klaus Steinmeyer , Gerhard Hessler
- Applicant: SANOFI
- Applicant Address: FR Paris
- Assignee: Sanofi
- Current Assignee: Sanofi
- Current Assignee Address: FR Paris
- Agency: McDonnell Boehnen Hulbert & Berghoff LLP
- Priority: EP12305129 20120203
- Main IPC: A61K31/5383
- IPC: A61K31/5383 ; C07D471/04 ; C07D498/04 ; C07D513/04
Abstract:
The present invention relates in fused pyrroledicarboxamides of the formula (I), in which R1 to R9, X, m and n are as defined in claims. The compounds of the formula (I) are inhibitors of the acid-sensitive potassium channel TASK-1 and suitable for the treatment of TASK-1 channel-mediated diseases such as arrhythmias, in particular atrial arrhythmias like atrial fibrillation or atrial flutter, and respiratory disorders, in particular sleep-related respiratory disorders like sleep apnea, for example.
Public/Granted literature
- US20160159793A1 Fused Pyrroledicarboxamides and Their Use as Pharmaceuticals Public/Granted day:2016-06-09
Information query
IPC分类:
